KP Tissue Inc. (TSE:KPT - Get Free Report) crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of C$11.46 and traded as high as C$12.92. KP Tissue shares last traded at C$12.82, with a volume of 28,347 shares trading hands.
Analyst Upgrades and Downgrades
A number of equities analysts have issued reports on KPT shares. Desjardins upped their target price on KP Tissue from C$12.00 to C$12.50 and gave the company a "hold" rating in a research report on Friday, May 15th. TD raised their price target on shares of KP Tissue from C$12.00 to C$14.00 and gave the stock a "hold" rating in a research report on Tuesday, July 14th. Three research analysts have rated the stock with a Hold rating, According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of C$12.12.
Read Our Latest Stock Analysis on KPT
KP Tissue Stock Performance
The firm has a market cap of C$128.56 million, a P/E ratio of 14.24, a P/E/G ratio of -0.88 and a beta of 0.53. The firm has a fifty day moving average of C$12.75 and a 200-day moving average of C$11.46.
KP Tissue (TSE:KPT - Get Free Report) last issued its quarterly earnings data on Thursday, May 14th. The company reported C$0.22 EPS for the quarter. Equities research analysts expect that KP Tissue Inc. will post 0.4398964 earnings per share for the current year.
KP Tissue Dividend Announcement
The company also recently announced a quarterly dividend, which was paid on Wednesday, July 15th. Shareholders of record on Wednesday, July 15th were paid a dividend of $0.21 per share. This represents a $0.84 dividend on an annualized basis and a yield of 6.6%. The ex-dividend date of this dividend was Tuesday, June 30th. KP Tissue's payout ratio is presently 80.00%.
Insider Buying and Selling
In other KP Tissue news, Director David A. Spraley sold 3,668 shares of the firm's stock in a transaction that occurred on Wednesday, June 17th. The shares were sold at an average price of C$13.30, for a total value of C$48,784.40. Following the sale, the director owned 15,712 shares in the company, valued at approximately C$208,969.60. This trade represents a 18.93% decrease in their ownership of the stock. In the last ninety days, insiders have sold 6,668 shares of company stock valued at $87,644. 0.14% of the stock is currently owned by corporate insiders.
About KP Tissue
(
Get Free Report)
KPT was created to acquire, and its business is limited to holding, a limited equity interest in Kruger Products, which is accounted for as an investment on the equity basis. KPT currently holds a 12% interest in Kruger Products.
Recommended Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider KP Tissue, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and KP Tissue wasn't on the list.
While KP Tissue currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.